Market segmentation
NGS-Based Monitoring and Diagnostic Test market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Also Read: http://www.marketwatch.com/story/ngs-based-monitoring-and-diagnosti...

Market segment by Type, covers
Commercial Assays/Tests
Laboratory Developed Tests
Direct to Consumer Test
Pre-Commercial Tests

Market segment by Application, can be divided into
Out-Patient Clinics/General Practitioners
Diagnostic Centers
Hospitals
Others

Also Read: http://www.marketwatch.com/story/petcare-packaging-market-research-...

Market segment by players, this report covers
Agilent Technologies, Inc.
Ancestry.com LLC
ArcherDX, Inc.
Beijing Genomics Institute (BGI)
Cancer Genetics, Inc.
CENTOGENE AG
F. Hoffmann-La Roche Ltd
GenePath Dx
Illumina, Inc.
Laboratory Corporation of America Holdings
Myriad Genetics, Inc.
QIAGEN N.V.
Quest Diagnostics Incorporated
Siemens Healthineers, Inc.
Thermo Fisher Scientific Inc.
HTG Molecular Diagnostics, Inc.
Vela Diagnostics Pte. Ltd.

Also Read: http://www.marketwatch.com/story/wind-power-spindle-market-research...

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

1 Market Overview
1.1 Product Overview and Scope of NGS-Based Monitoring and Diagnostic Test
1.2 Classification of NGS-Based Monitoring and Diagnostic Test by Type
1.2.1 Overview: Global NGS-Based Monitoring and Diagnostic Test Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global NGS-Based Monitoring and Diagnostic Test Revenue Market Share by Type in 2020
1.2.3 Commercial Assays/Tests
1.2.4 Laboratory Developed Tests
1.2.5 Direct to Consumer Test
1.2.6 Pre-Commercial Tests
1.3 Global NGS-Based Monitoring and Diagnostic Test Market by Application
1.3.1 Overview: Global NGS-Based Monitoring and Diagnostic Test Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Out-Patient Clinics/General Practitioners
1.3.3 Diagnostic Centers
1.3.4 Hospitals
1.3.5 Others
1.4 Global NGS-Based Monitoring and Diagnostic Test Market Size & Forecast
1.5 Global NGS-Based Monitoring and Diagnostic Test Market Size and Forecast by Region
1.5.1 Global NGS-Based Monitoring and Diagnostic Test Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global NGS-Based Monitoring and Diagnostic Test Market Size by Region, (2016-2021)
1.5.3 North America NGS-Based Monitoring and Diagnostic Test Market Size and Prospect (2016-2026)
1.5.4 Europe NGS-Based Monitoring and Diagnostic Test Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific NGS-Based Monitoring and Diagnostic Test Market Size and Prospect (2016-2026)
1.5.6 South America NGS-Based Monitoring and Diagnostic Test Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa NGS-Based Monitoring and Diagnostic Test Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 NGS-Based Monitoring and Diagnostic Test Market Drivers
1.6.2 NGS-Based Monitoring and Diagnostic Test Market Restraints
1.6.3 NGS-Based Monitoring and Diagnostic Test Trends Analysis
2 Company Profiles
2.1 Agilent Technologies, Inc.
2.1.1 Agilent Technologies, Inc. Details
2.1.2 Agilent Technologies, Inc. Major Business
2.1.3 Agilent Technologies, Inc. NGS-Based Monitoring and Diagnostic Test Product and Solutions
2.1.4 Agilent Technologies, Inc. NGS-Based Monitoring and Diagnostic Test Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Agilent Technologies, Inc. Recent Developments and Future Plans
2.2 Ancestry.com LLC
2.2.1 Ancestry.com LLC Details
2.2.2 Ancestry.com LLC Major Business
2.2.3 Ancestry.com LLC NGS-Based Monitoring and Diagnostic Test Product and Solutions
2.2.4 Ancestry.com LLC NGS-Based Monitoring and Diagnostic Test Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Ancestry.com LLC Recent Developments and Future Plans
2.3 ArcherDX, Inc.
2.3.1 ArcherDX, Inc. Details
2.3.2 ArcherDX, Inc. Major Business
2.3.3 ArcherDX, Inc. NGS-Based Monitoring and Diagnostic Test Product and Solutions
2.3.4 ArcherDX, Inc. NGS-Based Monitoring and Diagnostic Test Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 ArcherDX, Inc. Recent Developments and Future Plans
2.4 Beijing Genomics Institute (BGI)
2.4.1 Beijing Genomics Institute (BGI) Details
2.4.2 Beijing Genomics Institute (BGI) Major Business
2.4.3 Beijing Genomics Institute (BGI) NGS-Based Monitoring and Diagnostic Test Product and Solutions
2.4.4 Beijing Genomics Institute (BGI) NGS-Based Monitoring and Diagnostic Test Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Beijing Genomics Institute (BGI) Recent Developments and Future Plans
2.5 Cancer Genetics, Inc.
2.5.1 Cancer Genetics, Inc. Details
2.5.2 Cancer Genetics, Inc. Major Business
2.5.3 Cancer Genetics, Inc. NGS-Based Monitoring and Diagnostic Test Product and Solutions
2.5.4 Cancer Genetics, Inc. NGS-Based Monitoring and Diagnostic Test Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Cancer Genetics, Inc. Recent Developments and Future Plans
2.6 CENTOGENE AG
2.6.1 CENTOGENE AG Details
2.6.2 CENTOGENE AG Major Business
2.6.3 CENTOGENE AG NGS-Based Monitoring and Diagnostic Test Product and Solutions
2.6.4 CENTOGENE AG NGS-Based Monitoring and Diagnostic Test Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 CENTOGENE AG Recent Developments and Future Plans
2.7 F. Hoffmann-La Roche Ltd
2.7.1 F. Hoffmann-La Roche Ltd Details
2.7.2 F. Hoffmann-La Roche Ltd Major Business
2.7.3 F. Hoffmann-La Roche Ltd NGS-Based Monitoring and Diagnostic Test Product and Solutions
2.7.4 F. Hoffmann-La Roche Ltd NGS-Based Monitoring and Diagnostic Test Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 F. Hoffmann-La Roche Ltd Recent Developments and Future Plans
2.8 GenePath Dx
2.8.1 GenePath Dx Details
2.8.2 GenePath Dx Major Business
2.8.3 GenePath Dx NGS-Based Monitoring and Diagnostic Test Product and Solutions
2.8.4 GenePath Dx NGS-Based Monitoring and Diagnostic Test Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 GenePath Dx Recent Developments and Future Plans
2.9 Illumina, Inc.
2.9.1 Illumina, Inc. Details
2.9.2 Illumina, Inc. Major Business
2.9.3 Illumina, Inc. NGS-Based Monitoring and Diagnostic Test Product and Solutions
2.9.4 Illumina, Inc. NGS-Based Monitoring and Diagnostic Test Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Illumina, Inc. Recent Developments and Future Plans
2.10 Laboratory Corporation of America Holdings
2.10.1 Laboratory Corporation of America Holdings Details
2.10.2 Laboratory Corporation of America Holdings Major Business
2.10.3 Laboratory Corporation of America Holdings NGS-Based Monitoring and Diagnostic Test Product and Solutions
2.10.4 Laboratory Corporation of America Holdings NGS-Based Monitoring and Diagnostic Test Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Laboratory Corporation of America Holdings Recent Developments and Future Plans
2.11 Myriad Genetics, Inc.
2.11.1 Myriad Genetics, Inc. Details
2.11.2 Myriad Genetics, Inc. Major Business
2.11.3 Myriad Genetics, Inc. NGS-Based Monitoring and Diagnostic Test Product and Solutions
2.11.4 Myriad Genetics, Inc. NGS-Based Monitoring and Diagnostic Test Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Myriad Genetics, Inc. Recent Developments and Future Plans
2.12 QIAGEN N.V.
2.12.1 QIAGEN N.V. Details
2.12.2 QIAGEN N.V. Major Business
2.12.3 QIAGEN N.V. NGS-Based Monitoring and Diagnostic Test Product and Solutions
2.12.4 QIAGEN N.V. NGS-Based Monitoring and Diagnostic Test Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 QIAGEN N.V. Recent Developments and Future Plans
2.13 Quest Diagnostics Incorporated
2.13.1 Quest Diagnostics Incorporated Details
2.13.2 Quest Diagnostics Incorporated Major Business
2.13.3 Quest Diagnostics Incorporated NGS-Based Monitoring and Diagnostic Test Product and Solutions
2.13.4 Quest Diagnostics Incorporated NGS-Based Monitoring and Diagnostic Test Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Quest Diagnostics Incorporated Recent Developments and Future Plans
2.14 Siemens Healthineers, Inc.
2.14.1 Siemens Healthineers, Inc. Details
2.14.2 Siemens Healthineers, Inc. Major Business
2.14.3 Siemens Healthineers, Inc. NGS-Based Monitoring and Diagnostic Test Product and Solutions
2.14.4 Siemens Healthineers, Inc. NGS-Based Monitoring and Diagnostic Test Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 Siemens Healthineers, Inc. Recent Developments and Future Plans
2.15 Thermo Fisher Scientific Inc.
2.15.1 Thermo Fisher Scientific Inc. Details
2.15.2 Thermo Fisher Scientific Inc. Major Business

…….Continued

CONTACT DETAILS :

[email protected]

+44 203 500 2763

+1 62 825 80070

971 0503084105